DADC
CRL icon

D.A. Davidson & Co’s Charles River Laboratories CRL Stock Holding History

D.A. Davidson & Co’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-141
Closed -$9K – 2202
2015
Q2 		$9K Buy
141
+4
+3% +$296 ﹤0.01% 1886
2015
Q1 		$10K Sell
137
-559
-80% -$41.2K ﹤0.01% 1791
2014
Q4 		$44K Sell
696
-40
-5% -$2.51K ﹤0.01% 1469
2014
Q3 		$43K Buy
736
+42
+6% +$2.4K ﹤0.01% 1474
2014
Q2 		$37K Buy
694
+19
+3% +$1.04K ﹤0.01% 1498
2014
Q1 		$40K Sell
675
-159
-19% -$9.27K ﹤0.01% 1463
2013
Q4 		$44K Sell
834
-95
-10% -$4.77K ﹤0.01% 1362
2013
Q3 		$42K Buy
929
+209
+29% +$9.59K ﹤0.01% 1173
2013
Q2 		$29K Buy
+720
New +$30.8K ﹤0.01% 1232

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

D.A. Davidson & Co's CRL Position: Q3 2015 in Review

D.A. Davidson & Co sold out of Charles River Laboratories (CRL) in Q3 2015, closing a stake of 141 shares — an estimated $9K sold.

D.A. Davidson & Co first reported a position in CRL in Q2 2013 and held it in 9 quarters. The position peaked at $44K in Q4 2014. 258 funds tracked by Wall St. Rank hold CRL as of Q3 2015.

  • D.A. Davidson & Co reported no remaining Charles River Laboratories position as of Q3 2015 after selling out during the quarter.
  • D.A. Davidson & Co sold 141 Charles River Laboratories shares in Q3 2015, an estimated $9K.
  • D.A. Davidson & Co first reported a position in Charles River Laboratories in Q2 2013 and held it in 9 quarters.
  • D.A. Davidson & Co's Charles River Laboratories position peaked at $44K in Q4 2014.
  • 258 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2015.

Based on D.A. Davidson & Co's 13F filing for Q3 2015, filed 13 Nov 2015.